Hans‐Joachim Schmoll

University Hospital in Halle (DE)

Research Areas

Discover Papers by Hans‐Joachim Schmoll

Access 250+ million papers and cite this researcher's work with AI assistance

Try AnswerThis Free →

H-index

Publications

1035

Citations

37726

i10-index

361

Publications & Citations Over Time

Top Cited Publications

Want to find and read papers by this researcher? AnswerThis gives you instant access.

Title	Year	Citations
ESMO consensus guidelines for the management of pa...	2016	3416
ESMO Consensus Guidelines for management of patien...	2012	1524
Survival of Patients With Advanced Colorectal Canc...	2004	1079
Capecitabine Plus Oxaliplatin Compared With Fluoro...	2011	783
AJCC Cancer Staging Manual, 6th edition	2003	736
European Consensus Conference on Diagnosis and Tre...	2008	616
Chemoimmunotherapy with methotrexate, cytarabine, ...	2016	594
Bevacizumab plus oxaliplatin-based chemotherapy as...	2012	522
A Review of the Evolution of Systemic Chemotherapy...	2014	514
European consensus on diagnosis and treatment of g...	2004	512

Publications

1.
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
Year: 2016Citations: 3416DOI: 10.1093/annonc/mdw235
2.
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
Year: 2012Citations: 1524DOI: 10.1093/annonc/mds236
3.
Survival of Patients With Advanced Colorectal Cancer Improves With the Availability of Fluorouracil-Leucovorin, Irinotecan, and Oxaliplatin in the Course of Treatment
Year: 2004Citations: 1079DOI: 10.1200/jco.2004.11.037
4.
Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer
Year: 2011Citations: 783DOI: 10.1200/jco.2010.33.6297
5.
AJCC Cancer Staging Manual, 6th edition
Year: 2003Citations: 736DOI: 10.1093/annonc/mdg077
6.
European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I
Year: 2008Citations: 616DOI: 10.1016/j.eururo.2007.12.024
7.
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial
Year: 2016Citations: 594DOI: 10.1016/s2352-3026(16)00036-3
8.
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial
Year: 2012Citations: 522DOI: 10.1016/s1470-2045(12)70509-0
9.
A Review of the Evolution of Systemic Chemotherapy in the Management of Colorectal Cancer
Year: 2014Citations: 514DOI: 10.1016/j.clcc.2014.11.002
10.
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)
Year: 2004Citations: 512DOI: 10.1093/annonc/mdh301

About Hans‐Joachim Schmoll

Hans‐Joachim Schmoll is a researcher with 1035 publications and 37726 citations. They are affiliated with University Hospital in Halle. Their research focuses on . With an h-index of 97, they are among the top researchers in their field.

Citation Distribution

Distribution of citations across publications

Research Smarter

AnswerThis uses AI to help you search, understand, and cite research from Hans‐Joachim Schmoll and 250M+ other papers.

AI-powered research assistance
Automatic citations and references
Advanced academic writing tools

Research Area Breakdown

Publication Types

Publication type data not available

Impact Metrics Over Time

Citations per publication by year